Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.
about
RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usageAdvances in the characterization of RNA-binding proteinsCytoskeleton-Dependent Transport as a Potential Target for Interfering with Post-transcriptional HuR mRNA RegulonsAdaptive and maladaptive expression of the mRNA regulatory protein HuRPosttranscriptional regulation of cancer traits by HuRMultiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisPosttranscriptional regulation of p53 and its targets by RNA-binding proteinsIncreased PADI4 expression in blood and tissues of patients with malignant tumorsGastrointestinal hyperplasia with altered expression of DNA polymerase beta.The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitro.American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells.Differential protein occupancy profiling of the mRNA transcriptome.Resveratrol suppresses colitis and colon cancer associated with colitis.Wavelet- and Fourier-transform-based spectrum similarity approaches to compound identification in gas chromatography/mass spectrometry.COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation statusPost-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.Krüppel -like factor 8 is a stress-responsive transcription factor that regulates expression of HuR.Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsELAVL1 modulates transcriptome-wide miRNA binding in murine macrophagesThe RNA-binding protein HuR promotes glioma growth and treatment resistance.Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitorTNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells.Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells.HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation.The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibition.Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines.Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma.Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.RNA-binding protein RBM24 regulates p63 expression via mRNA stability.HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.Clinical significance of HuR expression in human malignancy.
P2860
Q24609537-A15AF598-696E-49A4-9641-BCC7EB43D354Q26738495-55886DB4-3F29-4005-A767-01DD36FD4036Q26827136-5C32FBF0-C003-4128-A312-0DFDE03DB78AQ26865703-7EA310DD-7D2C-4939-B0C0-2E4622576CBBQ28248667-7FDCEA8A-DEAB-4DC7-A609-10FFB809E602Q28290458-6B302A04-40DF-4513-AABF-C7454F57A05DQ28387511-85753B12-BE81-4090-993C-1B2B61750F62Q33404427-6491723C-2235-4E04-94D5-76AC7D1E4FB0Q33490616-C662A49D-7FC3-448D-8B1E-A7A223B24909Q33570640-1D77537D-88AA-49AB-9319-279F59DA5FD9Q33707992-05593287-3128-467B-B46B-EA9D0C09706FQ33751471-CF93908D-0A19-48B5-B496-88420688033CQ33785741-5E91ACA0-0CAA-43E6-B1AD-15B1D1CE2C27Q33925916-6A1E0DB2-3392-4243-8D33-F881A73A87DAQ33930978-067E251D-AB6B-4C42-897B-81C5040EDA55Q34065213-575C1800-8E10-4F79-8718-25F32A1E558DQ34117694-A873E5CB-A160-4EAF-8C2C-634AD950C1EAQ34491276-07EA715F-5DFF-4396-B384-480D1C33800FQ34777377-3D322817-854C-46A0-AD31-388BC126C65DQ34988117-C7CB0853-CD72-477D-AD8F-279631F1AEA3Q35057027-7608EE1B-0608-401D-8904-589CD53FCEC9Q35159634-E061D5A9-8FF2-45FA-9E62-4F3897F80B11Q35887700-2146B5B4-03EB-44E1-9CD7-F1DD062C8234Q36373369-3B70EC3B-3E12-42EB-87E3-70944C078BF7Q36445265-CD620A1A-8084-4A4E-BB18-E275100A7E04Q36481823-CE338330-6247-4C1D-9577-ACBBB8EA5A8AQ36622908-0835B6F5-69A3-455D-91B0-C73212C8B17DQ36804966-50D0BFA6-635F-47BB-AC2F-874F7509D104Q37066933-4FA0EADC-49D6-4BFB-9FFD-FE4884B4463EQ37092393-F2ACB536-7D3F-48CF-8888-987854CE38D6Q37180861-217AC398-54F0-40CB-BB77-4E63E478661BQ37192669-E43B1E27-EA38-446C-ABA5-BE91689AB80BQ37232962-B6D7EA1A-768D-4923-8027-69717036A1D8Q37325542-CFDB56B4-B677-4CC0-A5BC-434D2950D648Q37354557-0C2A26A5-FA95-47E6-A54A-5DD5B78F7CCCQ37656329-0CDF977E-4684-43E5-9FF4-661C82466433Q37662142-018D423C-FF3E-440B-9AE6-058E18EC9392Q37687521-3760809E-3130-47E4-B588-FA19D7405FA8Q37891908-DBD7E66B-024D-4870-8CA4-44FB1EF94449Q38238932-78D12ABD-5510-4BBF-B740-55068597D302
P2860
Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression of the ELAV-like pr ...... or stage and cyclooxygenase-2.
@en
type
label
Expression of the ELAV-like pr ...... or stage and cyclooxygenase-2.
@en
prefLabel
Expression of the ELAV-like pr ...... or stage and cyclooxygenase-2.
@en
P50
P1433
P1476
Expression of the ELAV-like pr ...... or stage and cyclooxygenase-2.
@en
P2093
Nora von Keyserlingk
P2888
P304
P356
10.1038/MODPATHOL.3800645
P577
2006-06-23T00:00:00Z
P5875
P6179
1052427776